View up-to-date information on PRA Health Sciences Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 02 Aug 2021 | Ascendis Pharma AS Enters Phase III Clinical Trial Agreement with PRA Health Sciences Inc for ACP-014 (GDCT0428798) | Contract Service Agreement |
Ascendis Pharma AS
|
PRA Health Sciences Inc |
| 23 Jul 2021 | Johnson & Johnson Enters Phase I Clinical Trial Agreement with PRA Health Sciences Inc for nipocalimab (GDCT0427610) | Contract Service Agreement |
Johnson & Johnson
|
PRA Health Sciences Inc |
| 19 Jul 2021 | Eisbach Bio GmbH Enters Phase I/II Clinical Trial Agreement with PRA Health Sciences Inc for Small Molecules for Coronavirus Disease 2019 (COVID-19) (GDCT0426003) | Contract Service Agreement |
Eisbach Bio GmbH
|
PRA Health Sciences Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer